Vassiliki Magafa

607 total citations
46 papers, 504 citations indexed

About

Vassiliki Magafa is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vassiliki Magafa has authored 46 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vassiliki Magafa's work include Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (5 papers). Vassiliki Magafa is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Neuropeptides and Animal Physiology (5 papers). Vassiliki Magafa collaborates with scholars based in Greece, United States and Czechia. Vassiliki Magafa's co-authors include Paul Cordopatis, George Stavropoulos, Andreas G. Tzakos, Georgios A. Spyroulias, Ioannis P. Gerothanassis, E. Manessi‐Zoupa, Jiřina Slaninová, Aikaterini A. Zompra, Nick Hadjiliadis and M. Liakopoulou‐Kyriakides and has published in prestigious journals such as The Journal of Immunology, European Journal of Biochemistry and Phytochemistry.

In The Last Decade

Vassiliki Magafa

45 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vassiliki Magafa Greece 13 299 68 63 62 56 46 504
Anne Wijkhuisen France 13 278 0.9× 59 0.9× 90 1.4× 59 1.0× 21 0.4× 33 559
Uwe Klein United States 12 625 2.1× 71 1.0× 37 0.6× 190 3.1× 127 2.3× 18 1.0k
Paulo C. Almeida Brazil 11 291 1.0× 24 0.4× 77 1.2× 83 1.3× 17 0.3× 16 703
Junji Emura Japan 8 531 1.8× 34 0.5× 61 1.0× 254 4.1× 32 0.6× 12 674
Paavo K.J. Kinnunen Finland 18 505 1.7× 58 0.9× 48 0.8× 36 0.6× 107 1.9× 26 1.0k
Daniela Bertinetti Germany 20 816 2.7× 27 0.4× 72 1.1× 151 2.4× 92 1.6× 41 1.0k
Nicholas A. Saccomano United States 14 707 2.4× 43 0.6× 151 2.4× 199 3.2× 88 1.6× 22 972
Scott Cosmi United States 17 168 0.6× 33 0.5× 82 1.3× 34 0.5× 10 0.2× 23 582
Anthony J. Lanzetti United States 11 471 1.6× 76 1.1× 37 0.6× 102 1.6× 11 0.2× 14 737
Lorena A. Kallal United States 13 732 2.4× 67 1.0× 44 0.7× 291 4.7× 38 0.7× 25 895

Countries citing papers authored by Vassiliki Magafa

Since Specialization
Citations

This map shows the geographic impact of Vassiliki Magafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vassiliki Magafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vassiliki Magafa more than expected).

Fields of papers citing papers by Vassiliki Magafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vassiliki Magafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vassiliki Magafa. The network helps show where Vassiliki Magafa may publish in the future.

Co-authorship network of co-authors of Vassiliki Magafa

This figure shows the co-authorship network connecting the top 25 collaborators of Vassiliki Magafa. A scholar is included among the top collaborators of Vassiliki Magafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vassiliki Magafa. Vassiliki Magafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gioran, Anna, Nikolaos Papandreou, Vassiliki Magafa, et al.. (2024). Beneficial Effects of Sideritis clandestina Extracts and Sideridiol against Amyloid β Toxicity. Antioxidants. 13(3). 261–261. 5 indexed citations
2.
Louros, Nikolaos, et al.. (2021). Arabidopsis thaliana Plant Natriuretic Peptide Active Domain Forms Amyloid-like Fibrils in a pH-Dependent Manner. Plants. 11(1). 9–9. 2 indexed citations
3.
Moschonas, Iraklis C., Tahsin F. Kellici, Thomas Mavromoustakos, et al.. (2017). Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand. Platelets. 28(8). 812–821. 10 indexed citations
4.
Sturchler, Emmanuel, Giuseppe Rengo, Vassiliki Magafa, et al.. (2016). Structure–activity relationship study of angiotensin II analogs in terms ofβ‐arrestin‐dependent signaling to aldosterone production. Pharmacology Research & Perspectives. 4(2). e00226–e00226. 22 indexed citations
5.
Kritsi, Eftichia, Minos–Timotheos Matsoukas, Constantinos Potamitis, et al.. (2016). Exploring new scaffolds for angiotensin II receptor antagonism. Bioorganic & Medicinal Chemistry. 24(18). 4444–4451. 9 indexed citations
6.
Louros, Nikolaos, Paraskevi L. Tsiolaki, Aikaterini A. Zompra, et al.. (2015). Structural studies and cytotoxicity assays of “aggregation‐prone” IAPP8–16 and its non‐amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin. Biopolymers. 104(3). 196–205. 20 indexed citations
7.
Ishiguro, Susumu, Kiyoshi Yoshimura, Ryouichi Tsunedomi, et al.. (2015). Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Biology & Therapy. 16(2). 307–316. 20 indexed citations
8.
Κουτσιούμπα, Μαρίνα, Constantinos M. Mikelis, Panagiotis Katsoris, et al.. (2012). Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin. PubMed. 4(1). 4–4. 35 indexed citations
9.
Lymperopoulos, Anastasios, Giuseppe Rengo, Vassiliki Magafa, Paul Cordopatis, & Walter J. Koch. (2010). Biased Agonism/Antagonism of β-Arrestin Activation by the Angiotensin II Type 1 Receptor: A Study of Sartans and Angiotensin II Analogs Using Aldosterone Turnover as a Readout. Journal of Cardiac Failure. 16(8). S30–S31. 1 indexed citations
10.
Magafa, Vassiliki, Lenka Borovičková, Jiřina Slaninová, & Paul Cordopatis. (2009). Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study. Amino Acids. 38(5). 1549–1559. 8 indexed citations
11.
Fragiadaki, Maria, Vassiliki Magafa, Lenka Borovičková, Jiřina Slaninová, & Paul Cordopatis. (2007). Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7. European Journal of Medicinal Chemistry. 42(6). 799–806. 12 indexed citations
12.
Dai, Yang, Daniel McCormick, Yi-chi M. Kong, et al.. (2005). Thyroxine-Binding Antibodies Inhibit T Cell Recognition of a Pathogenic Thyroglobulin Epitope. The Journal of Immunology. 174(5). 3105–3110. 12 indexed citations
13.
Saroglou, Vasiliki, Sophia Hatziantoniou, Ioanna Kyrikou, et al.. (2005). Synthesis, liposomal formulation and thermal effects on phospholipid bilayers of leuprolide. Journal of Peptide Science. 12(1). 43–50. 12 indexed citations
14.
Zompra, Aikaterini A., Georgios A. Spyroulias, Vassiliki Magafa, & Paul Cordopatis. (2005). Synthesis and Structural Investigation of a Synthetic LHRH Analogue in Solution. ChemInform. 36(13). 1 indexed citations
15.
Zompra, Aikaterini A., Vassiliki Magafa, Fotini N. Lamari, et al.. (2005). GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on breast cancer cells. Journal of Peptide Research. 66(s1). 57–64. 14 indexed citations
16.
Fragiadaki, Maria, Vassiliki Magafa, Jiřina Slaninová, & Paul Cordopatis. (2003). Synthesis and biological evaluation of oxytocin analogues containing l-α-t-butylglycine [Gly(But)] in positions 8 or 9. Peptides. 24(9). 1425–1431. 5 indexed citations
17.
Spyroulias, Georgios A., Andreas G. Tzakos, Ioannis P. Gerothanassis, et al.. (2003). Comparison of the solution structures of angiotensin I & II. European Journal of Biochemistry. 270(10). 2163–2173. 44 indexed citations
18.
Magafa, Vassiliki, et al.. (1998). Interaction of Hg(II) with tetrapeptides containing cysteinyl and histidinyl residues. Inorganica Chimica Acta. 272(1-2). 7–17. 10 indexed citations
19.
Ho, Wen‐Zhe, George Stavropoulos, Jianping Lai, et al.. (1998). Substance P C-terminal octapeptide analogues augment tumor necrosis factor-α release by human blood monocytes and macrophages. Journal of Neuroimmunology. 82(2). 126–132. 29 indexed citations
20.
Papaioannou, Dionissios, Constantinos M. Athanassopoulos, Vassiliki Magafa, et al.. (1995). Facile Preparation of the 1-Hydroxybenzotriazolyl Ester of N-Tritylpyroglutamic Acid and its Application to the Synthesis of TRH, [D-His2]TRH and Analogues Incorporating cis- and trans-4-Hydroxy-L-proline.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 49. 103–114. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026